Latest News

Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities

New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Multiple sclerosis: Review of current treatments for physicians

  • Researchers compare hip width and sexual behavior

  • Some astronauts at risk for cognitive impairment, animal studies suggest

  • Hearing quality restored with bionic ear technology used for gene therapy: Re-growing auditory nerves

  • Finding safe drugs to treat neurodegenerative diseases

  • Loss of memory in Alzheimer's mice models reversed through gene therapy

  • Novel compound halts cocaine addiction, relapse behaviors

  • Safer alternatives to nonsteroidal antinflamatory pain killers

  • Mystery behind general anesthetic action becoming more clear

  • Narrowing of neck artery without warning may signal memory, thinking decline

  •